Portola Pharmaceuticals (Portola Pharmaceuticals) Days Payable : 276.64 (As of Mar. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Portola Pharmaceuticals Days Payable?

Portola Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2020 was $13.1 Mil. Portola Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2020 was $4.3 Mil. Hence, Portola Pharmaceuticals's Days Payable for the three months ended in Mar. 2020 was 276.64.

The historical rank and industry rank for Portola Pharmaceuticals's Days Payable or its related term are showing as below:

PTLA's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

Portola Pharmaceuticals's Days Payable increased from Mar. 2019 (146.53) to Mar. 2020 (276.64). It may suggest that Portola Pharmaceuticals delayed paying its suppliers.

Portola Pharmaceuticals Days Payable Historical Data

The historical data trend for Portola Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portola Pharmaceuticals Days Payable Chart

Portola Pharmaceuticals Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Days Payable

Get a 7-Day Free Trial

10,488.25

227.29

106.73

Portola Pharmaceuticals Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Days Payable	Get a 7-Day Free Trial															146.53	197.27	435.04	40.91	276.64

Competitive Comparison of Portola Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Portola Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portola Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portola Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Portola Pharmaceuticals's Days Payable falls into.

Portola Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Portola Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2019 is calculated as

	Days Payable (A: Dec. 2019 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2018 )	+	Accounts Payable (A: Dec. 2019 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2019 )	*	Days in Period
=	( (13.215	+	12.739)	/	2 )	/	44.378	*	365
=	12.977					/	44.378	*	365
=	106.73

Portola Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2020 is calculated as:

	Days Payable (Q: Mar. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2019 )	+	Accounts Payable (Q: Mar. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2020 )	*	Days in Period
=	( (12.739	+	13.455)	/	2 )	/	4.32	*	365 / 4
=	13.097					/	4.32	*	365 / 4
=	276.64

Portola Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Portola Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Portola Pharmaceuticals (Portola Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portola Pharmaceuticals Inc (NAS:PTLA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

270 E. Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.portola.com

Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Executives

Dennis M Fenton	director
John B Moriarty	officer: EVP, General Counsel	ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Hollings Renton	director
David C Stump	director
Ted W Love	director	C/O GLOBAL BLOOD THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO CA 94080
John Johnson	director	DENDREON CORPORATION, 1301 2ND AVENUE, SEATTLE WA 98101
Jeffrey W Bird	director	755 PAGE MILL RD STE A-200, PALO ALTO CA 94304-1005
Henry Ward Wolff	director	6701 KAISER DRIVE, FREMONT CA 94555
J. Scott Garland	director, officer: President and CEO	210 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Laura Brege	director	C/O ONYX PHARMACEUTICALS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Mardi Dier	officer: EVP and CFO	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Rajiv Patni	officer: EVP, CMO	C/O OCERA THERAPEUTICS, INC., 525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO CA 94301
John T Curnutte	officer: EVP R&D	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Charles J Homcy	other: Former Director	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
William Lis	director, officer: Chief Executive Officer	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080